Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 45.16% is 40% above its 5-year average of 32.19%, around the middle of its 5-year range (0.71%–92.41%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.81% below its 12-month average of 53.64%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 45.16%.
DEBT TO ASSETS RATIO
45.16%
DEBT TO ASSETS RATIO AVG TTM
53.64%
DEBT TO ASSETS RATIO AVG 3Y
45.02%
DEBT TO ASSETS RATIO AVG 5Y
32.19%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-15.81%
CURRENT VS 3Y AVG
+0.30%
CURRENT VS 5Y AVG
+40.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+50075.55%
vs the sector median at left
Elicio Therapeutics, Inc.
Market Cap
$36.23M
Debt to Assets Ratio
45.16%
TTM Avg
53.64%
3Y Avg
45.02%
5Y Avg
32.19%
Market Cap
$36.28M
Debt to Assets Ratio
0.14%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.50M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.48M
Debt to Assets Ratio
1.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.98M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$34.50M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | $36.23M | 45.16% | 53.64% | 45.02% | 32.19% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | 0.14% | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $35.71M | 0.14% | N/A | N/A | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.50M | 0.00% | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $35.48M | 1.40% | N/A | N/A | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $36.98M | 0.00% | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $34.62M | 0.25% | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $37.89M | 0.06% | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.50M | 0.00% | N/A | N/A | N/A |
| Incannex Healthcare Limited (IXHL)vs › | $37.97M | 0.00% | N/A | N/A | N/A |
Debt/Assets
45.2%
Debt/Equity
1.78
Current Ratio
2.77
Interest Coverage
-33.3x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 45.16% |
| 2026-03-31 | 63.20% |
| 2025-12-31 | 56.11% |
| 2025-09-30 | 53.24% |
| 2025-06-30 | 50.47% |
| 2025-03-31 | 20.58% |
| 2024-12-31 | 92.41% |
| 2024-09-30 | 67.86% |
| 2024-06-30 | 40.76% |
| 2024-03-31 | 27.25% |
| 2023-12-31 | 25.48% |
| 2023-09-30 | 23.08% |
| 2023-06-30 | 19.68% |
| 2023-03-31 | 0.71% |
| 2022-12-31 | 33.01% |
| 2022-09-30 | 6.45% |
| 2022-03-31 | 5.46% |
| 2021-12-31 | 4.83% |
| 2021-09-30 | 4.16% |
| 2021-06-30 | 3.81% |
| 2021-03-31 | 1.69% |
| 2020-12-31 | 179.61% |
| 2020-09-30 | 305.63% |
| 2019-12-31 | 90.68% |
